Aflibercept targets and sequesters multiple forms of VEGF, including VEGF-A, VEGF-B, and PlGF. These growth factors are crucial for the formation of new blood vessels, which tumors need for oxygen and nutrients. By blocking these factors, aflibercept starves the tumor of its blood supply, thereby slowing or stopping its growth.
